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Socioeconomic disadvantage has been linked to reduced
access to kidney transplantation. To understand and address
potential barriers to transplantation, we used the Australia
and New Zealand Dialysis and Transplant Registry and
examined primary kidney-only transplantation among adult
non-Indigenous patients who commenced chronic renal
replacement therapy in Australia during 2000–2010.
Socioeconomic status was derived from residential postcodes
using standard indices. Among the 21,190 patients who
commenced renal replacement therapy, 4105 received a
kidney transplant (2058 from living donors (660 preemptive)
or 2047 from deceased donors) by the end of 2010.
Compared with the most socioeconomic disadvantaged
quartile, patients from the most advantaged quartile were
more likely to receive a preemptive transplant (relative rate
1.93), and more likely to receive a living-donor kidney
(adjusted subhazard ratio 1.34) after commencing dialysis.
Socioeconomic status was not associated with deceased-
donor transplantation. Thus, the association between
socioeconomic status and living- but not deceased-donor
transplantation suggests that potential donors (rather than
recipients) from disadvantaged areas may face barriers to
donation. Although the deceased-donor organ allocation
process appears essentially equitable, it differs between
Australian states.
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Kidney transplantation provides the optimal survival1,2 and
quality of life3 for patients with end-stage kidney disease.
Socioeconomically disadvantaged patients have previously
been found to be less likely to receive kidneys from both
living4–6 and deceased7,8 donors in both the United States and
the United Kingdom. Socioeconomic disparities in access to
kidney transplantation have been found in high-income
countries with universal health care,9 including Italy10 and
the United Kingdom,5 and in countries without universal
health care, such as the United States.4 However, this has not
been investigated previously in Australia, a country with
universal access to health care and a mix of public and private
health-care providers. Separate investigations into preemp-
tive, living-donor, and deceased-donor transplantation can
highlight what disparities and barriers exist. Furthermore,
most studies into socioeconomic status (SES) and access to
transplantation have used standard proportional hazard
models, with no allowance for competing risks such as death.
We investigated associations between SES and access to
transplantation in Australia, with preemptive transplants,
and live- and deceased-donor transplants considered sepa-
rately, as well as potential confounders and covariates, using
competing risk regression.
RESULTS
In total, 21,190 patients were included in this study, of whom
4105 had received a kidney transplant in Australia by 31
December 2010. Among primary transplants, 2058 were from
living donors and 2047 from deceased donors. The median
age at commencement of renal replacement therapy (RRT)
was 64 years, and 64% of patients had one or more
comorbidities. Patients from disadvantaged areas were
slightly younger, but had overall greater comorbidity at
commencement of RRT compared with patients from
advantaged areas (Table 1). Living-donor kidneys came from
parents (25%), spouses (27%), other relatives (32%), and
unrelated donors (16%), and these proportions did not
change with SES (w9
2¼ 8, d.f.¼ 9, P¼ 0.5). Overall, 660
(3.2%) of incident patients received a preemptive transplant
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(that is, before any dialysis), and this was more common
among patients from advantaged areas. The relative rate (RR)
for the most advantaged versus most disadvantaged quartile
was 1.93 (95% confidence interval (CI) 1.39–2.68; Po0.001;
Figure 1). All preemptively transplanted kidneys were from
living donors. Waiting time for primary living-donor grafts
was much less than for deceased-donor grafts (Figure 2).
Patients from the most advantaged quartile were less likely to
be referred late to nephrological care (Table 1). The measure
of SES used reflects a range of factors including income, educa-
tion, employment type, and access to information (Figure 3).
Patients from advantaged postcodes were more likely to
receive a non-preemptive transplant from a living donor. The
competing risk subhazard ratio (SHR) for the most
advantaged when compared with the most disadvantaged
quartile of postcodes was 1.34 (95% CI 1.11–1.62, P¼ 0.002;
Figure 2). Conversely, SES was not associated with the
likelihood of receiving a deceased-donor kidney (SHR¼ 0.99;
95% CI 0.86–1.14; P¼ 0.4; Figure 2). Adjusting for patient age,
demographics, various indicators of health, and late referral
made little difference to the effects of SES within competing risk
models. Cox models suggested larger associations between
SES and deceased-donor transplantation than competing risk
models, although both models led to similar conclusions
(Table 2). There was some association between race and SES
among non-Indigenous RRT patients—the proportion of
Caucasian patients was highest in the second and third
quartiles, but there was no overall trend when analyzed with
SES quartiles as a continuous variable (w3
2¼ 0.5, P¼ 0.5).
For completeness, we repeated all analyses with Indigen-
ous Australians included, and found that this made very little
difference to associations between SES and transplantation.
Similarly, including each comorbidity as a separate covariate
made no discernible difference to the results.
Patient demographics, health, and gender
Advanced age, presence of comorbidities, type of primary
kidney disease, and smoking status were all associated with
decreased likelihood of receiving any type of kidney graft
(Po0.002, Figure 4). SES had a marginally larger effect on
patients aged 18–39 years at commencement of RRT rather
than older patients, who were unlikely to receive a
preemptive transplant regardless of SES (w2
2¼ 5, P¼ 0.08
for the age category: SES interaction; Figure 1).
Patients with comorbidities were considerably less likely to
receive any type of transplant (Figure 4). There were no
significant interactions between SES and comorbidity
burden, race, remoteness, state, previously diagnosed cancer,
or body mass index category on the likelihood of receiving a
preemptive transplant (P40.2).
There was no gender disparity in access to preemptive
transplants (P¼ 0.9, Figure 4). Males were more likely to
receive a non-preemptive transplant with a living-donor
kidney (RR¼ 1.22, 95% CI 1.09–1.37; Po0.0007) or a
Table 1 | Patients who commenced RRT in Australia from 2000 to 2010
Factor
Quartile 1
(disadvantaged) Quartile 2 Quartile 3
Quartile 4
(advantaged) P-value
N 3351 4213 6723 6568
Preemptive 2.0% 2.6% 3.4% 3.9% o0.001
Male 62% 61% 62% 63% 0.5
Caucasian 86% 90% 88% 86% o0.001
Major city 50% 50% 74% 95% o0.001
Age, median (IQR) 64 (52–72) 64 (52–73) 64 (51–74) 65 (52–75) o0.001
Cancer 11% 13% 12% 13% o0.001
Smoker 56% 55% 52% 48% o0.001
Chronic lung disease 18% 18% 16% 14% o0.001
Peripheral vascular disease 30% 26% 27% 22% o0.001
Cerebrovascular disease 16% 16% 16% 14% 0.008
Diabetes 43% 38% 38% 33% o0.001
Kidney disease: Glomerulonephritis 21% 20% 20% 22% o0.001
Diabetic nephritis + hypertension 45% 42% 43% 40%
Polycystic 6% 8% 7% 8%
Other 28% 30% 30% 30%
eGFR, median (IQR) 7.1 (5.5–9.7) 7.3 (5.5–9.8) 7.5 (5.5–10.0) 7.5 (5.6–10.0) o0.001
Late referral 24% 24% 24% 22% 0.02
BMI
Underweight 2.4% 3.6% 3.4% 4.3% o0.001
Normal weight 33.4% 34.1% 36.3% 40.5%
Overweight 34.5% 32.2% 33.4% 32.7%
Obese+ 29.7% 30.1% 26.8% 22.5%
Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate; IQR, interquartile range; RRT, renal replacement therapy.
Indigenous patients, those o18 years, and recipients of multiple organs were excluded. Postcodes were divided into quartiles using socioeconomic status (SES) scores.
Comorbidities were known or suspected: chronic lung, coronary artery, diabetes, and peripheral and cerebrovascular diseases, and eGFR was calculated using the four-
variable Modification of Diet in Renal Disease (MDRD) formula.45 Smoking status (former or current) was at commencement of RRT, and late referral was defined as being
referred to a nephrologist o3 months before commencing RRT.
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deceased-donor kidney (RR¼ 1.20, 95% CI 1.09–1.31;
P¼ 0.0001). Females were more affected by SES than males
(Figure 1; w1
2¼ 6, P¼ 0.01 for the gender: SES interaction for
preemptive transplants). Late referral had a stronger effect on
preemptive transplantation than for other types of grafts,
although it was associated with decreased access to all types
of grafts (Figure 4).
Era
Compared with patients who started RRT in 2000–2004,
patients who started in 2005–2009 were more likely to receive
a preemptive transplant (RR¼ 1.57, 95% CI 1.15–2.13,
P¼ 0.004) or a non-preemptive living-donor transplant
(SHR¼ 1.25; 95% CI 1.10–1.41; P¼ 0.001). There was no
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Figure 1 |Percentage of patients commencing renal replacement therapy (RRT) who received a preemptive kidney transplant
in Australia versus area socioeconomic status (SES). (a) All patients. Patients were stratified by (b) gender, (c) number of comorbidities,
and (d) age. Results shown have not been adjusted. The x-axis (SES) shows postcodes grouped into quartiles based on SES, with some
values staggered slightly for clarity. Error bars show 95% confidence intervals (CIs), calculated from binomial distribution. Y scales vary
between panels.
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Figure 2 |Unadjusted nonparametric cumulative incidence of
first transplantation from (left) a living donor (including
preemptive transplants) and (right) a deceased donor for
patients from disadvantaged and advantaged areas. Time is
taken from start of renal replacement therapy. Living-donor
curves were calculated with patient death or receipt of a
deceased-donor kidney as competing risks. Similarly, deceased-
donor curves were calculated with patient death or receipt of a
living-donor kidney as competing risks.
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Figure 3 |Relationship between quartiles of postcode based
on the Index of Relative Socioeconomic Advantage and
Disadvantage and personal earnings, education, occupation
type, and household internet access. Data presented are raw
data from the 2006 Australian Census. Home internet access is for
all households, other lines show data for non-Indigenous
Australian individuals aged 20–69 years.
Table 2 | Estimates of the effects of socioeconomic status,
comparing the most advantaged quartile of postcodes with
the most disadvantaged quartile (the reference group)
Living-donor
transplants
(all P-values o0.005)
Deceased-donor
transplants
Competing risk,
unadjusted
1.40 (1.18–1.65) 0.96 (0.85–1.10), P=0.6
Competing risk, adjusted 1.33 (1.10–1.60) 0.99 (0.86–1.13), P=0.9
Cox model, adjusted 1.34 (1.11–1.62) 1.05 (0.91–1.21), P=0.5
Patients who received preemptive transplants were excluded. Adjusted values are
from models that include: state, remoteness, primary kidney disease, gender, age
group, smoking status, number of comorbidities, race, body mass index (BMI)
category, previous diagnosis of cancer, and late referral as covariates. Cells show
subhazard ratios (competing risks), hazard ratios (Cox models) with 95% confidence
interval (CI), and associated P-values.
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difference in the rate of deceased-donor transplantation
between eras (SHR¼ 0.93; 95% CI 0.82–1.06; P¼ 0.3). There
was no interaction between SES and era for any type of
transplantation (P40.3; Figure 5).
Geography
SES varied between states (w4
2¼ 64, Po0.001): 38.9% of
postcodes in New South Wales and Australian Capital
Territory were in the most advantaged quartile when
compared with 18.4% of postcodes in South Australia and
the Northern Territory. However, there were no differences
between states (w4
2¼ 6, P¼ 0.2), and no significant interac-
tions between state and SES in the likelihood of a patient
receiving a preemptive transplant (w4
2¼ 2.5, P¼ 0.7). There
were, however, differences between states in the likelihood of
receiving a transplant after commencing dialysis, with the
best-performing state for living-donor transplants having a
SHR of 1.43 (95% CI 1.19–1.71) and the best-performing
state for deceased-donor transplants having a SHR of 3.76
(95% CI 3.24–4.36) compared with the most populous state.
The effects of SES were similar across all states (w4
2¼ 2.9,
P¼ 0.6 for the state/SES interaction).
Patients living outside major cities were more likely to
receive a preemptive (P¼ 0.02) or subsequent living-donor
graft (Po0.0001), but less likely to receive a deceased-donor
kidney (P¼ 0.03; Figure 4). There was no significant
interaction between urban/rural location and SES in the
likelihood of receiving a preemptive transplant (w1
2¼ 0.34,
P¼ 0.6). Advantaged postcodes were more likely to be in
major cities (w3
2¼ 619, Po0.001). Only 7% of postcodes
outside of major cities were in the most advantaged quartile,
compared with 54% of postcodes within major cities.
DISCUSSION
Patients from advantaged areas were more likely to receive a
graft from a living donor, both before and after commence-
ment of dialysis. However, SES was not associated with the
likelihood of receiving a kidney from a deceased donor.
Younger, healthier patients, nonsmokers, and males were
more likely to receive a transplant from any source, and
patients from disadvantaged areas generally had more
comorbidities and higher prevalence of smoking and obesity.
The relationship between SES and transplantation has not
changed significantly since 2000.
Socioeconomic disadvantage is likely to pose a range of
barriers to receiving a living-donor kidney. Donors and
recipients must be medically suitable and the burden of
morbidity is greater and harmful health-related behaviors
more common among people who live in disadvantaged
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Figure 4 |Association between likelihood of receiving a transplant and patient socioeconomic status (SES), demographics, and
health. The preemptive transplant graph shows relative rates from Poisson regression; other living- and deceased-donor graphs show
subhazard ratios from competing risk regressions, with models adjusted for all other covariates in graphs. Points show exponentiated
coefficients, and bars show 95% confidence intervals. Reference groups (dots on the vertical line¼ 1) are not shown for clarity.
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Figure 5 |Cumulative incidence of any transplant by
socioeconomic status (SES) and era. Disadvantaged patients
lived in 50% of postcodes with the lowest score and advantaged
patients in 50% of postcodes with the highest score. Patients were
censored on 31 December 2005 (left panel) and 31 December
2009 (right panel).
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areas.11–15 Although higher levels of comorbidity (or under-
reporting and thus underadjustment for comorbidities with-
in models) within potential recipients may be important, this
is not likely to be a factor, given the absence of a SES-related
trend for deceased-donor transplants. Disadvantaged areas
have proportionally more single parents,16 and parents
provided 25% of living-donor kidneys. However, we found
no evidence that the makeup of donor/recipient relationships
varied with SES. Patients from advantaged areas are more
likely to have timely referral to nephrological care,17 and late-
referred patients are less likely to receive a kidney
transplant;18 however, adjusting for late referral made little
difference to SES gradients.
Patient education is determined by individual transplant-
ing hospitals, and there is likely also to be some education by
nephrologists from referring centers, dialysis nursing staff,
and a number of others. Although patient education is a
strong determinant of access to transplantation, especially in
the United States,19 the ANZDATA Registry does not collect
data on this. There is no standard pretransplant assessment
process in Australia, and ANZDATA (Australia and New
Zealand Dialysis and Transplant Registry) does not collect
details of any referral for transplantation or workup. It is
possible that advantaged patients receive earlier care and
pretransplant workup, which may be one factor leading to
more preemptive transplants. Potential donors with limited
financial resources may not be able to afford time off work or
away from family commitments to undergo workup or
nephrectomy.20 They may also face direct costs related to
testing and transport to hospitals, and may have reduced
family and social support perioperatively. Patients may also
be less willing to approach potential donors for fear of
causing financial burden.21 There is no specific compensation
for kidney donors beyond standard sick leave entitlements
(typically 2 weeks per year), or out-of-pocket medical and
related expenses. One state (Western Australia) introduced a
system for reimbursing living donors for expenses related to
travel, accommodation, and meals in 2006,22 and preliminary
analyses suggest an increase in preemptive transplantation
rates in this state around this time (data not shown). The
United Kingdom has provisions for reimbursing donors, but
these may not be applied uniformly.6
We found no association between SES and likelihood of
receiving a kidney from a deceased donor in Australia. This is
a crucial difference in findings from this study compared with
results from the United States4 and United Kingdom,7,8 which
have shown reduced access to both living- and deceased-
donor transplants for disadvantaged patients. These differ-
ences may be because of variation in the structure of health-
care systems, subsidies, algorithms used to allocate deceased-
donor kidneys, and other factors that cannot be quantified
with registry data. The process for allocating deceased-donor
kidneys in Australia gives considerable weight to time spent
on waiting list.23
Australia provides universal access to government-funded
health care, whereas disadvantaged US citizens are less likely
to have insurance, and may face significant out-of-pocket
costs for many services. Australians from advantaged areas
are more likely to have additional health insurance and are
more likely to receive additional screening and elective
surgery,24 as well as improved access to specialist and allied
health care. This may explain lower rates of late referral in
advantaged areas. Socioeconomic disparities in uptake of
health care have been implicated in higher rates of end-stage
kidney disease among disadvantaged Australians,25 as has
been found for other diseases.26 The United Kingdom also
provides universal access to health care, but still has
socioeconomic disparities in access to kidney transplantation
for deceased-donor kidneys,5,8,27 suggesting that other barriers
exist for disadvantaged people in the United Kingdom.
Kidney transplantation is only performed in publicly funded
hospitals in Australia.
For US patients, transplantation results in more out-of-
pocket costs for patients than dialysis, which may deter some
disadvantaged patients.28 Many US patients lose Medicare
funding for immunosuppressive drugs 3 years after trans-
plantation,4 whereas Australian and UK transplant recipients
receive subsidized immunosuppressive drugs for the life of
the graft, although they still face some out-of-pocket
expenses for these medications. These expenses (and entitle-
ments) are similar to those faced by patients on dialysis.
Papers investigating disparities in access to transplantation
have used different starting points, end points, or analytical
techniques. Studies from the United States often investigate
access to waiting lists,7,19 or transplantation among patients
who are placed on the waiting list.4,29 However, time from
commencing dialysis to receiving a transplant is the
important determinant of patient health. For this reason,
researchers from other countries often analyze time from
commencing RRT to receiving a transplant.8,30 Although
such differences make international comparisons difficult,
access to transplantation among US patients on the waiting
list was similar to our current results for Australian patients
on RRT.4 Hall et al.29 found that much of the racial
differences in access to transplantation in the United States
was because of variation in transplantation rates of patients
who were waitlisted.
One key strength of this analysis is that we used competing
risk regression, whereas most investigations in this field have
used Cox survival models, which assume that censored
patients are similar to those who remain in the analysis pool.
In an analysis of deceased-donor transplants, patients would
be censored in a Cox proportional hazard models if they
received a living-donor kidney, despite patients who receive a
living-donor kidney being generally younger, healthier, and
coming from more advantaged areas. Treating such patients
as identical to those who remain on the waiting list for
deceased-donor kidneys would violate assumptions of
independent censoring. This informative censoring often
results in Cox models producing inflated estimates. Choice of
model made no real difference to analyses of living-donor
transplantation, where there were few competing events (few
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deaths or deceased-donor transplants before living-donor
transplants). However, Cox models produced inflated
adjusted hazard ratios for SES advantage, and did not detect
differences between major cities and more remote areas in
access to deceased-donor kidneys, whereas competing risk
models did detect such trends. Despite the use of competing
risk models, we cannot rule out the possibility that
interactions between living-donor and deceased-donor
transplantation may reduce apparent associations between
deceased-donor transplants and SES. The comparatively high
rate of living-donor transplants among advantaged patients
may mean that many suitable patients from advantaged areas
are unlikely to receive a deceased-donor transplant.
Our analyses demonstrated differences in access to
transplantation between states, and within states, as well as
remoteness, which deserve further investigation. However, the
effects of SES were consistent between states. Most kidneys are
transplanted in the same state that they were donated,31 and
the Australian deceased-donor kidney allocation process
ensures that each state receives the same number of kidneys
as they contribute to the pool. As there is substantial variation
in the deceased-donor rates between states, much of the
variation between states may reflect the availability of kidneys.
This paper focused on SES, and these geographical variations
warrant separate detailed investigation.
Some potential barriers to transplantation cannot be
ascertained with registry data, such as patient knowledge and
education about transplantation, which have been identified
as a barrier to deceased-donor transplantation in the United
States.32 Educating suitable dialysis patients about transplan-
tation reduced racial disparities in time to waitlisting.19 In
addition, determining whether a patient is suitable for
transplantation is often subjective,32,33 and SES disparities
may exist at this step in Australia.
This study has several strengths: the completeness and
national coverage of the ANZDATA registry, completeness of
postcode records, the size of the sample, the use of
standardized SES indices, and the use of competing risk
regressions that allow systematic analyses of both live- and
deceased-donor transplantation. The major limitation of this
study is that postcode-level data were the only SES indices
available from the ANZDATA registry. Such Australian
postcode-level SES indices can be reliable, and are regularly
used, estimates of individual SES.34 Area-level SES also
predicts health independently of individual-level SES.26,35
Compared with the US ZIP codes, Australian postcodes are
considerably smaller, possibly making them more accurate
estimates of individual-level SES, although increased SES
heterogeneity within remote postcodes may confound some
results. Unmeasured or incompletely measured covariates,
such as comorbidity, may contribute to associations
between SES and transplantation. Blood group and human
leukocyte antigen panel reactive antibody measures are
likely to be important covariates, but may not be strongly
correlated with SES.36 However, SES was not associated with
access to deceased-donor grafts, suggesting that SES may
have a true effect and not due to underadjustment for
confounders.
In these analyses, we found no association between SES
and access to kidneys from deceased donors in Australia. This
is reassuring, given that these are a scarce societal resource.
Australians from advantaged areas were, however, more likely
to receive a kidney from a live donor (both for preemptive
and subsequent transplants). Financial barriers (especially for
donors) and higher rates of comorbidities may preclude
family members from becoming living donors. If rates of live-
kidney transplantation are to be increased for disadvantaged
Australians, future research must clearly identify such barriers.
MATERIALS AND METHODS
Patients
Patients aged X18 years, who were recorded in the ANZDATA
Registry as commencing RRT (chronic dialysis or kidney transplan-
tation) in Australia in 2000–2010, were included in this study.
ANZDATA has complete coverage of all dialysis and transplantation
centers in Australia, and all patients are included in the registry
unless they specifically request otherwise. Patients were excluded if
they received a transplant outside of Australia (N¼ 19), they
received any organ in addition to a kidney (N¼ 274), or if they self-
reported as being Indigenous Australians (N¼ 2166). The markedly
reduced transplant access experienced by Indigenous Australians37
might confound the effect of SES, and the requirement for many
Indigenous patients to relocate before commencing RRT would
undermine the reliability of area-based estimates of SES.38
Outcomes
We investigated the proportions of patients who received a
preemptive kidney transplant (that is, before any dialysis). Among
patients who commenced dialysis before receiving a transplant, we
investigated time from commencing dialysis to receiving a primary
transplant, and whether this was from a living or a deceased donor.
Predictors
We used Australian postcode (analogous to US ZIP code) as area
units. In 2006, Australian postcodes had a median population of
3323 people (interquartile range of 788–11,351), which is fewer than
US ZIP codes or census tracts. Postcodes were ranked using the
Australian Bureau of Statistics’ Index of Relative Advantage and
Disadvantage, similar to previous studies into associations between
SES and RRT.39 This index is derived from 2006 census data on
income, education, employment status, occupation type, housing,
internet access, disability status, car ownership, and single parent
status.40 Postcodes were divided into quartiles of SES, with quartile
1 being the most disadvantaged. Forty-nine patients (o0.3%) were
excluded because of difficulties in matching residential postcodes in
ANZDATA to those used by the Bureau of Statistics. Each postcode
was assigned a remoteness index—either major city or other
(regional, remote, or very remote)—using Australian Standard
Geographical Classification, 2006.41
Analyses
All analyses were conducted with the following as covariates: age
group (18–39, 40–59, and 60þ years), gender, body mass index
(o18.5, 18.5–24.9, 25–29.9, and 30þ kg/m2), smoking status,
number of comorbidities (diabetes, chronic lung disease, coronary
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artery disease, peripheral vascular disease, and cerebrovascular
disease), primary kidney disease, racial origin (self-reported
Caucasian vs. other non-Indigenous), state of residence, late referral,
and whether their postcode corresponded to a major city. Primary
kidney diseases were grouped into four categories: diabetes and
hypertension; glomerulonephritis; polycystic kidney disease; and all
others. Australian states and territories were grouped according to
transplant region.23 Patients who were referred to nephrological care
within 3 months of commencing RRT were considered to be ‘late
referrals.’ Unadjusted analyses were also included for comparison.
Demographic factors were compared between advantaged and
disadvantaged postcodes using either w2 tests (gender, race,
comorbidities, smoking, and kidney disease late referral) or
Mann–Whitney U-tests.
We used Poisson regression, with variance clustered by treating
hospital, to investigate RRs (which are analogous to relative risks for
binary outcomes) for patients receiving a preemptive transplant
(transplant as the first mode of RRT) between quartiles of area
SES.42 This was repeated, including interactions between SES and
gender, age group, number of comorbidities, race (Caucasian vs.
other non-Indigenous people), state, and remoteness, with SES as a
continuous variable. Analyses were repeated again, including a
comparison of patients who commenced RRT in 2000–2004
(censored at the end of 2004) to those who commenced in
2005–2009 (censored at the end of 2009). Analyses of SES/state and
SES/era interactions were conducted in separate analyses.
The likelihood of receiving the first kidney transplant over time
was analyzed using competing risk proportional subhazard models
on time from commencing RRT to receiving a transplant, using the
method of Fine and Gray.43 Patients who received preemptive
transplants were not included to avoid violating the assumption of
constant proportional hazards. The ‘risk’ of receiving a kidney from
a living donor was modeled with patient death and deceased-donor
transplantation as competing risks. Similarly, the risk of receiving a
deceased-donor kidney was modeled with death and living-donor
transplantation as competing risks. Results are expressed as SHRs,
which are analogous to hazard ratios produced by Cox regressions.
For comparison, survival analyses were repeated using Cox
proportional hazard models, and with Indigenous Australians
included. The assumption of constant proportional subhazards
was checked by plotting Shoenfeld-like residuals and by
investigating a SES: time interaction term within the model.
Cumulative incidence graphs were produced using nonparametric
techniques.44 Analyses were repeated, comparing patients who
commenced in RRT 2000–2004 (censored at the end of 2004) to
patients who commenced in 2005–2009. Interactions between
SES and states and era were also investigated in separate analyses.
Among patients who received living-donor transplants, the relation-
ship between donor and recipient (parent, spouse, other relative, or
nonrelative) was compared between quartiles of postcodes using
Pearson’s w2 test.
Unless stated explicitly, all values for RR and SHRs are adjusted
and presented with 95% CIs. All analyses were conducted using
Stata 12 IC (StataCorp, College Station, TX).
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